Vaccine industry, as an important branch of pharmaceutical industry, is highly valued by governments and grand pharmaceutical enterprises worldwide with the flooding of kinds of pandemic flu virus recently.

At present China is the biggest vaccine producer in the world. Vaccine industry is quite hot in China since it is supported and pushed by both Chinese government and enterprises.
 

Now the most central topices are the lastest law of domestic vaccine market, the future of vaccine industry and the leading technology of vaccine development.The China Vaccine Technology and Development Congress was held from Jan. 14 to Jan. 15, 2010 in beijing under the above-mentioned topices.

During this congress, the participants were mainly focus on the following topics:

▲ the policy and regulation of China vaccine industry-the influence by China medical reform,the lastest policy as well as the tendency of vaccine industry, national vaccine inoculability plan.
▲vaccine registration-the classification of vaccine and the process of vaccine registration.
▲ technology of vaccine development-the research findings by leading vaccine enterprise from both at home and abroad.
▲ production process of vaccine-scaling up, downstreaming purification and adjuvant application of vaccine.
▲ the strategy of vaccine distribution-the lowest cost and the highest rate of  market distribution.
Zhongyuan, the largest domestic distributor in bio-science area attended this congress as exhibitor from the beginning to the end. Zhongyuan  communicated with other exhibitors and visitors throughly. As agent of ATCC/GE/3M/BD and other branded bio-enterprises, Zhongyuan and its professional sales staffs won high reputation in this congress.
 

Under our mission“Promoting life science enterprise & Focusing on public health”，Beijing Zhongyuan Ltd. will continuously aims in constructing the largest bio-science products distribution platform in China and serve the different kinds of customers in life science fields especially in vaccine industry.